Literature DB >> 25100707

Influence of AKT on progesterone action in endometrial diseases.

Irene I Lee1, J Julie Kim2.   

Abstract

Progesterone plays an essential role in the maintenance of the endometrium; it prepares the endometrium for pregnancy, promotes decidualization, and inhibits estrogen-dependent proliferation. Progesterone function is often dysregulated in endometrial disease states. In addition, the PI3K/AKT signaling pathway is often overactive in endometrial pathologies and promotes the survival and proliferation of the diseased cells. Understanding how AKT influences progesterone action is critical in improving hormone-based therapies in endometrial pathologies. Here, we summarize recent studies investigating the crosstalk between the AKT pathway and progesterone receptor function in endometriosis and endometrial cancer.
© 2014 by the Society for the Study of Reproduction, Inc.

Entities:  

Keywords:  cancer; endometriosis; endometrium; progesterone/progesterone receptor; signal transduction

Mesh:

Substances:

Year:  2014        PMID: 25100707      PMCID: PMC4435059          DOI: 10.1095/biolreprod.114.119255

Source DB:  PubMed          Journal:  Biol Reprod        ISSN: 0006-3363            Impact factor:   4.285


  156 in total

1.  Increased activation of the PI3K/AKT pathway compromises decidualization of stromal cells from endometriosis.

Authors:  Xunqin Yin; Mary Ellen Pavone; Zhenxiao Lu; JianJun Wei; J Julie Kim
Journal:  J Clin Endocrinol Metab       Date:  2011-11-09       Impact factor: 5.958

2.  Akt suppresses androgen-induced apoptosis by phosphorylating and inhibiting androgen receptor.

Authors:  H K Lin; S Yeh; H Y Kang; C Chang
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-12       Impact factor: 11.205

3.  The deficiency of Akt1 is sufficient to suppress tumor development in Pten+/- mice.

Authors:  Mei-Ling Chen; Pei-Zhang Xu; Xiao-ding Peng; William S Chen; Grace Guzman; Ximing Yang; Antonio Di Cristofano; Pier Paolo Pandolfi; Nissim Hay
Journal:  Genes Dev       Date:  2006-06-15       Impact factor: 11.361

4.  DNA methylation patterns of steroid receptor genes ESR1, ESR2 and PGR in deep endometriosis compromising the rectum.

Authors:  Joana Ladeira Meyer; Daniela Zimbardi; Sérgio Podgaec; Renee Laufer Amorim; Maurício Simões Abrão; Cláudia Aparecida Rainho
Journal:  Int J Mol Med       Date:  2014-01-28       Impact factor: 4.101

5.  FOXO1A differentially regulates genes of decidualization.

Authors:  Oscar L Buzzio; Zhenxiao Lu; Curt D Miller; Terry G Unterman; J Julie Kim
Journal:  Endocrinology       Date:  2006-05-11       Impact factor: 4.736

6.  The opposing transcriptional activities of the two isoforms of the human progesterone receptor are due to differential cofactor binding.

Authors:  P H Giangrande; E A Kimbrel; D P Edwards; D P McDonnell
Journal:  Mol Cell Biol       Date:  2000-05       Impact factor: 4.272

7.  The G protein-coupled receptor GPR30 mediates the proliferative effects induced by 17beta-estradiol and hydroxytamoxifen in endometrial cancer cells.

Authors:  Adele Vivacqua; Daniela Bonofiglio; Anna Grazia Recchia; Anna Maria Musti; Didier Picard; Sebastiano Andò; Marcello Maggiolini
Journal:  Mol Endocrinol       Date:  2005-10-20

8.  Pten is essential for embryonic development and tumour suppression.

Authors:  A Di Cristofano; B Pesce; C Cordon-Cardo; P P Pandolfi
Journal:  Nat Genet       Date:  1998-08       Impact factor: 38.330

9.  Increased mitogen-activated protein kinase kinase/extracellularly regulated kinase activity in human endometrial stromal fibroblasts of women with endometriosis reduces 3',5'-cyclic adenosine 5'-monophosphate inhibition of cyclin D1.

Authors:  Michael C Velarde; Lusine Aghajanova; Camran R Nezhat; Linda C Giudice
Journal:  Endocrinology       Date:  2009-07-09       Impact factor: 4.736

Review 10.  Prostate cancer progression after androgen deprivation therapy: mechanisms of castrate resistance and novel therapeutic approaches.

Authors:  T Karantanos; P G Corn; T C Thompson
Journal:  Oncogene       Date:  2013-06-10       Impact factor: 9.867

View more
  18 in total

1.  Inhibition of PI3K/AKT/mTOR pathway for the treatment of endometriosis.

Authors:  Fabio Barra; Lorenzo Ferro Desideri; Simone Ferrero
Journal:  Br J Pharmacol       Date:  2018-07-08       Impact factor: 8.739

2.  Reply to the letter from Barra et al.

Authors:  Sachiko Matsuzaki; Jean-Luc Pouly; Michel Canis
Journal:  Br J Pharmacol       Date:  2018-07-08       Impact factor: 8.739

3.  Influence of Cancer-Associated Endometrial Stromal Cells on Hormone-Driven Endometrial Tumor Growth.

Authors:  M J Pineda; Z Lu; D Cao; J J Kim
Journal:  Horm Cancer       Date:  2015-05-15       Impact factor: 3.869

4.  Dysregulation of the interleukin-17A pathway in endometrial tissue from women with unexplained infertility affects pregnancy outcome following assisted reproductive treatment.

Authors:  D A Crosby; L E Glover; E P Brennan; P Kelly; P Cormican; B Moran; F Giangrazi; P Downey; E E Mooney; B J Loftus; F M McAuliffe; M Wingfield; C O'Farrelly; D J Brennan
Journal:  Hum Reprod       Date:  2020-08-01       Impact factor: 6.918

5.  A Causal Link Between Disrupted AKT Signaling and Hyperproliferative Endometrial Diseases.

Authors:  James K Pru
Journal:  Endocrinology       Date:  2022-03-01       Impact factor: 4.736

6.  Decreased Progesterone Receptor B/A Ratio in Endometrial Cells by Tumor Necrosis Factor-Alpha and Peritoneal Fluid from Patients with Endometriosis.

Authors:  Uisoo Chae; Jin Young Min; Sung Hoon Kim; Hyo Jin Ihm; Young Sang Oh; So Yun Park; Hee Dong Chae; Chung Hoon Kim; Byung Moon Kang
Journal:  Yonsei Med J       Date:  2016-11       Impact factor: 2.759

7.  Expression of CPPED1 in human trophoblasts is associated with timing of term birth.

Authors:  Antti M Haapalainen; Minna K Karjalainen; Ravindra Daddali; Steffen Ohlmeier; Julia Anttonen; Tomi A Määttä; Annamari Salminen; Mari Mahlman; Ulrich Bergmann; Kaarin Mäkikallio; Marja Ojaniemi; Mikko Hallman; Mika Rämet
Journal:  J Cell Mol Med       Date:  2017-11-29       Impact factor: 5.310

8.  FKBP51 decreases cell proliferation and increases progestin sensitivity of human endometrial adenocarcinomas by inhibiting Akt.

Authors:  Jing Dong; Yulian Jiao; Wenli Mu; Bingru Lu; Muyun Wei; Linying Sun; Shengnan Hu; Bin Cui; Xiaowen Liu; Zijiang Chen; Yueran Zhao
Journal:  Oncotarget       Date:  2017-06-30

9.  Clinical and Expression Significance of AKT1 by Co-expression Network Analysis in Endometrial Cancer.

Authors:  Xiao Huo; Hengzi Sun; Qian Liu; Xiangwen Ma; Peng Peng; Mei Yu; Ying Zhang; Dongyan Cao; Keng Shen
Journal:  Front Oncol       Date:  2019-11-06       Impact factor: 6.244

10.  Metformin Promotes Anti-tumor Biomarkers in Human Endometrial Cancer Cells.

Authors:  John Mark P Pabona; Alexander F Burnett; Dustin M Brown; Charles M Quick; Frank A Simmen; Maria Theresa E Montales; Shi J Liu; Tyler Rose; Iad Alhallak; Eric R Siegel; Rosalia Cm Simmen
Journal:  Reprod Sci       Date:  2020-01-01       Impact factor: 3.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.